NASDAQ · Medical - Devices

Cerus Corporation (CERS) Stock

$2.30 +0.88% NASDAQ: CERS Healthcare

Valuation

MetricValue
Price$2.30
Market Cap$463.51M
P/E Ratio-62.98
P/B Ratio6.53
P/S Ratio2.07
EPS (TTM)$0.00
52-Week High$3.47
52-Week Low$1.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.31%
ROA-3.31%
ROCE-1.35%
Gross Margin-17.48%
Operating Margin-17.48%
Net Margin-3.06%
Debt/Equity1.10
Current Ratio1.72

Annual Financials (USD)

Metric20212022202320242025
Revenue$131.0M$162.0M$156.0M$180.0M$206.0M
Operating Profit$-49.0M$-34.0M$-30.0M$-14.0M$-9.0M
Net Profit$-54.0M$-43.0M$-37.0M$-21.0M$-16.0M
EPS$-0.32$-0.24$-0.21$-0.11$-0.08
Op Margin-37.4%-21.0%-19.2%-7.9%-4.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$237.0M$218.0M$198.0M$201.0M$222.0M
Total Liabilities$152.0M$150.0M$144.0M$144.0M$157.0M
Cash$49.0M$36.0M$12.0M$20.0M$20.0M
Borrowings$88.0M$87.0M$96.0M$98.0M$97.0M

Latest News

Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress Business Wire · Jun 17, 2026 Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M Insider Monkey · Jun 16, 2026 Cerus Corporation Closes New Debt Facility of Up to $110 Million Business Wire · Jun 8, 2026 Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year? Zacks · Jun 4, 2026 Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG Insider Monkey · May 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-26.0M$-43.0M$11.0M$11.0M
Investing Cash Flow$12.0M$6.0M$4.0M$-11.0M$-11.0M
Financing Cash Flow$10.0M$0$1.0M$0$5.0M
Net Cash Flow$12.0M$-14.0M$-24.0M$8.0M$8.0M
Free Cash Flow$-35.0M$-28.0M$-48.0M$9.0M$9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.57
EV / EBITDA178.23
FCF Yield-0.40%
Quick Ratio1.07
Interest Coverage-0.21
Return 1Y97.93%
Return 3Y0.35%
Return 5Y-35.91%

Ownership

Insiders Held3.40%
Institutions Held73.30%
Institutions Float Held75.89%
Institutional HolderSharesReport Date
Blackrock Inc.21,575,4192026-03-31
ARK Investment Management, LLC19,161,1482026-03-31
Soleus Capital Management, L.P.10,753,7002026-03-31
Baker Bros. Advisors, LP10,008,3452026-03-31
Vanguard Capital Management LLC8,131,7782026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADMAADMA Biologics Inc $10.36 +0.29% 14.08 $2.40B 0.00%
GRFSGrifols, S.A. $7.27 -0.27% 14.60 $6.15B 1.24%
HAEHaemonetics Corporation $118.69 -0.65% 50.65 $5.39B 0.00%

About Cerus Corporation

Cerus Corporation is led by CEO William Greenman, employs 614 people, headquartered in US, publicly traded since 1997.

Cerus Corporation (CERS) stock trades at $2.30 with a market capitalization of $463.51M. The stock is valued at a price-to-earnings (P/E) ratio of -62.98, price-to-book of 6.53, price-to-sales of 2.07. Over the past 52 weeks the stock has ranged between $1.38 and $3.47, and currently trades 33.7% below its 52-week high.

On profitability, Cerus Corporation generates a return on equity (ROE) of -10.31%, return on capital employed of -1.35%, an operating margin of -17.48%, a net profit margin of -3.06%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides